Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-23 Purchase |
2021-12-28 6:24 pm |
Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director |
1,100 | $9.9052 | $10,896 | 289,989 (Indirect Direct) |
View |
| 2021-12-17 Purchase |
2021-12-21 6:06 pm |
Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director |
200 | $9.88 | $1,976 | 288,889 (Indirect Direct) |
View |
| 2021-12-15 Purchase |
2021-12-15 8:09 pm |
Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director |
3,700 | $10.77 | $39,844 | 288,689 (Indirect Direct) |
View |
| 2021-06-22 Purchase |
2021-06-24 8:55 pm |
Cyteir Therapeutics Inc. | CYT | Droia Invest II SCSp Wepaven BV DF II GP Sarl IHL SA Verelst Luc Naesens Janwillem 10% Owner |
277,777 | $18 | $4,999,986 | 3,536,803 (Direct) |
View |
| 2021-06-22 Purchase |
2021-06-24 8:50 pm |
Cyteir Therapeutics Inc. | CYT | Naesens Janwillem Director |
277,777 | $18 | $4,999,986 | 3,536,803 (Indirect) |
View |
| 2021-06-22 Purchase |
2021-06-23 5:18 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
277,777 | $18 | $4,999,986 | 4,840,413 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-22 Option Award |
2022-02-24 5:03 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director |
14,150 | $0 | 14,150 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 5:02 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
106,200 | $0 | 106,200 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 5:01 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | Molineaux Susan Director |
14,150 | $0 | 14,150 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 5:00 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | Humphrey Jeffrey Director |
2,358 | $0 | 2,358 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 4:59 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | George Jean Director |
14,150 | $0 | 14,150 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 4:59 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | Bracken Racquel Director |
14,150 | $0 | 14,150 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 4:58 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | Romberger Timothy Director |
14,150 | $0 | 14,150 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 4:57 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | Naesens Janwillem Director |
14,150 | $0 | 14,150 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 4:57 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | Secrist John Paul Chief Scientific Officer |
42,000 | $0 | 42,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 4:57 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | Gengos Andrew Chief Business Officer |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 4:54 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Vice President, Finance |
23,000 | $0 | 23,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 4:53 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | Sands Stephen H. Director |
28,300 | $0 | 28,300 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-07 08:28 am |
N/A 2032-02-04 |
Cyteir Therapeutics Inc. | CYT | THERO JOHN F Director |
28,300 | $0 | 28,300 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-16 4:35 pm |
N/A 2031-12-15 |
Cyteir Therapeutics Inc. | CYT | Humphrey Jeffrey Director |
28,300 | $0 | 28,300 (Direct) |
View |
| 2021-06-22 Conversion |
2021-06-24 8:55 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Droia Invest II SCSp Wepaven BV DF II GP Sarl IHL SA Verelst Luc Naesens Janwillem 10% Owner |
14,368,394 | $0 | 3,536,803 (Direct) |
View |
| 2021-06-22 Conversion |
2021-06-24 8:54 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director |
258,671 | $0 | 284,989 (Indirect) |
View |
| 2021-06-22 Conversion |
2021-06-24 8:52 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Romberger Timothy Director |
348,563 | $0 | 369,448 (Direct) |
View |
| 2021-06-22 Conversion |
2021-06-24 8:50 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Naesens Janwillem Director |
14,368,394 | $0 | 3,536,803 (Indirect) |
View |
| 2021-06-22 Conversion |
2021-06-24 8:48 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | George Jean Director |
10,776,294 | $0 | 2,444,268 (Indirect) |
View |
| 2021-06-22 Conversion |
2021-06-23 5:18 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
20,115,752 | $0 | 4,840,413 (Direct) |
View |
| 2021-06-22 Conversion |
2021-06-23 4:08 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Venrock Associates VII L.P. Venrock Partners VII L.P. Venrock Management VII LLC 10% Owner |
14,368,393 | $0 | 3,259,025 (Direct) |
View |
Ownership |
2021-06-17 9:44 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Droia Invest II SCSp Wepaven BV Naesens Janwillem DF II GP Sarl IHL SA Verelst Luc 10% Owner |
0 | $0 | 3,259,025 (Direct) |
View |
Ownership |
2021-06-17 9:43 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director |
0 | $0 | 382,198 (Direct) |
View |
Ownership |
2021-06-17 9:43 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
0 | $0 | 4,562,636 (Direct) |
View |
Ownership |
2021-06-17 9:41 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Romberger Timothy Director |
0 | $0 | 386,697 (Direct) |
View |
Ownership |
2021-06-17 9:40 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Naesens Janwillem Director |
0 | $0 | 3,276,273 (Indirect) |
View |
Ownership |
2021-06-17 9:34 pm |
N/A 2031-06-17 |
Cyteir Therapeutics Inc. | CYT | Bracken Racquel Director |
0 | $0 | 17,250 (Direct) |
View |
Ownership |
2021-06-17 9:32 pm |
N/A 2030-12-09 |
Cyteir Therapeutics Inc. | CYT | Molineaux Susan Director |
0 | $0 | 60,427 (Direct) |
View |
Ownership |
2021-06-17 9:31 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | George Jean Director |
0 | $0 | 2,461,515 (Indirect) |
View |
Ownership |
2021-06-17 9:21 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Venrock Associates VII L.P. Venrock Partners VII L.P. Venrock Management VII LLC 10% Owner |
0 | $0 | 3,259,025 (Indirect) |
View |
Ownership |
2021-06-17 9:19 pm |
N/A 2030-12-10 |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Vice President, Finance |
0 | $0 | 106,755 (Direct) |
View |
Ownership |
2021-06-17 9:16 pm |
N/A 2030-07-21 |
Cyteir Therapeutics Inc. | CYT | Secrist John Paul Chief Scientific Officer |
0 | $0 | 378,683 (Direct) |
View |